Back

PRIME Education, Inc. (PRIME®)

  • Antibodies, Bispecific

Accelerating Evidence Into Practice: Latest Guidelines and Clinical Evidence for Bispecific Antibodies in R/R DLBCL and FL

In this first video podcast recorded during a recent live symposium at the American Society of Hematology (ASH) Annual Meeting, our expert panel will explore the evolving landscape of bsAb therapies, including a deep dive into FDA-approved CD20xCD3 bsAbs, NCCN guideline updates, and the latest safety and efficacy trial data. Don’t miss this opportunity to stay at the forefront of bsAb integration in R/R DLBCL and FL and download the actionable tools such as the Bispecific Antibody Integration Protocol and the Adverse Event Management Playbook, both designed to empower multidisciplinary teams in optimizing bsAb use.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Podcast / audio
  • includes On-demand / recorded video
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Dec 30, 2025
  • Last day to claim credit
    Dec 30, 2026 3 months left